Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Top 10 Papers in 2020
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • Call for Abstracts 2021
    • 2020 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Portugûes
    • 国语

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Top 10 Papers in 2020
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • Call for Abstracts 2021
    • 2020 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Portugûes
    • 国语
  • Follow aarc on Twitter
  • Visit aarc on Facebook
Research ArticleOriginal Contributions

Incorporating Tiotropium Into a Respiratory Therapist-Directed Bronchodilator Protocol for Managing In-Patients With COPD Exacerbations Decreases Bronchodilator Costs

Gail S Drescher, Bettye J Carnathan, Susan Imus and Gene L Colice
Respiratory Care December 2008, 53 (12) 1678-1684;
Gail S Drescher
Pulmonary Services Department, Washington Hospital Center, Washington DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Bettye J Carnathan
Pulmonary Services Department, Washington Hospital Center, Washington DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Imus
Pulmonary Services Department, Washington Hospital Center, Washington DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gene L Colice
Department of Pulmonary, Critical Care, and Respiratory Services, Washington Hospital Center, and with the Department of Medicine, School of Medicine, George Washington University, Washington DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

BACKGROUND: Tiotropium is used in maintenance treatment of chronic obstructive pulmonary disease (COPD), but there are no guidelines on when to start tiotropium following an exacerbation.

OBJECTIVE: To determine whether the addition of tiotropium to a respiratory-therapist-directed bronchodilator protocol affects bronchodilator costs for patients hospitalized for COPD exacerbation.

METHODS: We retrospectively analyzed data on the number and type of bronchodilator treatments administered to all patients admitted for COPD exacerbation during the 3-month period (January through March 2006) after tiotropium was added to our bronchodilator protocol, and compared that data to a historical control period (January through March 2004) before tiotropium was available in our hospital. We compared the costs of bronchodilator treatments, baseline patient characteristics, comorbidities, concomitant medications, length of stay, adverse events, and in-hospital deaths.

RESULTS: Baseline characteristics, comorbidities, and concomitant medications were similar in the 2004 control group (n = 181) and the 2006 intervention group (n = 174). The mean SD number of bronchodilator treatments per admission was significantly higher in the control period (13.6 ± 15.6) than in the intervention period (10.6 ± 9.4). That difference correlated to a reduction in combination therapy (short-acting inhaled β2 agonist plus ipratropium), which decreased from a per-admission average of 6.7 ± 14.2 in the control period to 1.9 ± 5.1 in the intervention period. Calculated bronchodilator costs were significantly lower in the intervention period than in the control period. Length of stay also significantly decreased, from 6.5 ± 5.0 d to 5.5 ± 4.0 d. There were no adverse events related to tiotropium. Pulmonary-related in-hospital deaths were not significantly different between the 2 periods.

CONCLUSIONS: Early addition of maintenance-treatment tiotropium to a respiratory-therapist-directed bronchodilator protocol for patients hospitalized for COPD exacerbation reduced costs and produced no safety concerns.

  • tiotropium bromide
  • chronic obstructive pulmonary disease
  • COPD exacerbation
  • respiratory therapist-directed bronchodilator protocol
  • COSTS
  • β2 AGONIST
  • long-acting inhaled bronchodilator
  • anticholinergic

Footnotes

  • Correspondence: Gail S Drescher MA RRT, Pulmonary Services Department, Washington Hospital Center, 110 Irving Street NW, Washington DC 20010;, Email: Gail.S.Drescher{at}medstar.net.
  • Gene L Colice MD has had relationships with GlaxoSmithKline, Boehringer Ingelheim, Pfizer, Eli Lilly, Abbott, Genentech, Almirall, Forrest, Adams, TEVA, OM Pharma, Nomura, and MedImmune. The authors report no other conflicts of interest related to the content of this paper.

  • Copyright © 2008 by Daedalus Enterprises Inc.
PreviousNext
Back to top

In this issue

Respiratory Care: 53 (12)
Respiratory Care
Vol. 53, Issue 12
1 Dec 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Incorporating Tiotropium Into a Respiratory Therapist-Directed Bronchodilator Protocol for Managing In-Patients With COPD Exacerbations Decreases Bronchodilator Costs
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Incorporating Tiotropium Into a Respiratory Therapist-Directed Bronchodilator Protocol for Managing In-Patients With COPD Exacerbations Decreases Bronchodilator Costs
Gail S Drescher, Bettye J Carnathan, Susan Imus, Gene L Colice
Respiratory Care Dec 2008, 53 (12) 1678-1684;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Incorporating Tiotropium Into a Respiratory Therapist-Directed Bronchodilator Protocol for Managing In-Patients With COPD Exacerbations Decreases Bronchodilator Costs
Gail S Drescher, Bettye J Carnathan, Susan Imus, Gene L Colice
Respiratory Care Dec 2008, 53 (12) 1678-1684;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Keywords

  • tiotropium bromide
  • chronic obstructive pulmonary disease
  • COPD exacerbation
  • respiratory therapist-directed bronchodilator protocol
  • costs
  • β2 agonist
  • long-acting inhaled bronchodilator
  • anticholinergic

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About Us
  • Editorial Board
  • Reprints/Permissions

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire